The Ohio Department of Health is updating webpages with the term "mpox" to reduce stigma and other issues associated with prior terminology. This change is aligned with the recent World Health Organization decision.
Mpox is a rare disease caused by infection with the mpox virus. When properly administered before an exposure, vaccines are effective at protecting people against mpox. Vaccination after a mypox exposure may help prevent the disease or make it less severe.
The JYNNEOS vaccine is approved for prevention of smallpox and mpox. It is the primary vaccine being used during this outbreak in the U.S. and here in Ohio.
The Ohio Department of Health offers a collection of resources for mpox vaccine providers about storage, handling and administration of the JYNNEOS vaccine.
- Mpox Vaccines Storage, Handling and Administration (Provider Traing Session)
- Mpox vaccine frequently asked questions for providers
- JYNNEOS Vaccine Storage and Handling Summary for Children and Teens
- JYNNEOS Vaccine Storage and Handling Summary for Adults
- How to administer JYNNEOS mpox vaccine intradermally
- Vaccine Record of Movement Form – Mpox
- How to Record Mpox Vaccine Transfer in VOMS
- CDC: HHS Mpox Vaccination Program Provider Agreement